Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Major Product Category by Reporting Segment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 175,204	$ 106,418
Change	64.60%
Bone Growth Therapies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 47,714	41,948
Change	13.70%
Spinal Implants And Enabling Technologies [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 60,862	26,615
Change	128.70%
Biologics [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 40,630	14,092
Change	188.30%
Global Spine [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 149,206	82,655
Change	80.50%
Global Orthopedics [Member]
Revenue Recognition And Accounts Receivable [Line Items]
Net sales	$ 25,998	$ 23,763
Change	9.40%